“Efficacy, Safety and tolerability of the once-daily 10 cm² rivastigmine patch formulation in the patients with dementia (with probable Alzheimer’s disease)”, Bangla. J. Neuroscience, vol. 29, no. 1, pp. 5–14, Jan. 2013, doi: 10.3329/bjn.v29i1.56165.